The Emerging Role of the Gut-Brain-Microbiota Axis in Neurodevelopmental Disorders. 2022

S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
School of Health & Biomedical Sciences, STEM College, RMIT University, Bundoora, VIC, Australia.

Autism spectrum disorder (ASD; autism) is a prevalent neurodevelopmental disorder associated with changes in gut-brain axis communication. Gastrointestinal (GI) symptoms are experienced by a large proportion of individuals diagnosed with autism. Several mutations associated with autism modify cellular communication via neuronal synapses. It has been suggested that modifications to the enteric nervous system, an intrinsic nervous system of the GI tract, could contribute to GI dysfunction. Changes in gut motility, permeability, and the mucosal barrier as well as shifts in the large population of microbes inhabiting the GI tract could contribute to GI symptoms. Preclinical research has demonstrated that mice expressing the well-studied R451C missense mutation in Nlgn3 gene, which encodes cell adhesion protein neuroligin-3 at neuronal synapses, exhibit GI dysfunction. Specifically, NL3R451C mice show altered colonic motility and faster small intestinal transit. As well as dysmotility, macrophages located within the gut-associated lymphoid tissue of the NL3R451C mouse caecum show altered morphology, suggesting that neuro-inflammation pathways are modified in this model. Interestingly, NL3R451C mice maintained in a shared environment demonstrate fecal microbial dysbiosis indicating a role for the nervous system in regulating gut microbial populations. To better understand host-microbe interactions, further clarification and comparison of clinical and animal model profiles of dysbiosis should be obtained, which in turn will provide better insights into the efforts taken to design personalized microbial therapies. In addition to changes in neurophysiological measures, the mucosal component of the GI barrier may contribute to GI dysfunction more broadly in individuals diagnosed with a wide range of neurological disorders. As the study of GI dysfunction advances to encompass multiple components of the gut-brain-microbiota axis, findings will help understand future directions such as microbiome engineering and optimisation of the mucosal barrier for health.

UI MeSH Term Description Entries
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D000067877 Autism Spectrum Disorder Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V) Autistic Spectrum Disorder,Autism Spectrum Disorders,Autistic Spectrum Disorders,Disorder, Autistic Spectrum
D000087502 Brain-Gut Axis An interactive network between the GASTROINTESTINAL TRACT (gut) and the brain principally mediated through the ENTERIC NERVOUS SYSTEM. Control of the gut activities during stress, for instance, is mediated by activation of neuroendocrine hormones (e.g., CORTICOTROPIN-RELEASING FACTOR). Conversely, INTESTINAL MICROBIOTA associate with the CENTRAL NERVOUS SYSTEM through the axis via microorganism-derived products (e.g., UROCORTINS). Some functional GASTROINTESTINAL DISORDERS (e.g., IRRITABLE BOWEL SYNDROME) have dysregulated brain-gut axis. Brain and Gut Axis,Brain-Gut-Microbiome Axis,Gut and Brain Axis,Gut-Brain Axis,Gut-Brain-Microbiome Axis,Microbiome-Brain-Gut Axis,Microbiome-Gut-Brain Axis,Microbiota-Brain-Gut Axis,Microbiota-Gut-Brain Axis,Axis, Brain-Gut,Axis, Brain-Gut-Microbiome,Axis, Gut-Brain,Axis, Gut-Brain-Microbiome,Axis, Microbiome-Brain-Gut,Axis, Microbiome-Gut-Brain,Axis, Microbiota-Brain-Gut,Axis, Microbiota-Gut-Brain,Brain Gut Axis,Brain Gut Microbiome Axis,Gut Brain Axis,Gut Brain Microbiome Axis,Microbiome Brain Gut Axis,Microbiome Gut Brain Axis,Microbiota Brain Gut Axis,Microbiota Gut Brain Axis
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D064307 Microbiota The full collection of microbes (bacteria, fungi, virus, etc.) that naturally exist within a particular biological niche such as an organism, soil, a body of water, etc. Human Microbiome,Microbiome,Microbiome, Human,Microbial Community,Microbial Community Composition,Microbial Community Structure,Community Composition, Microbial,Community Structure, Microbial,Community, Microbial,Composition, Microbial Community,Human Microbiomes,Microbial Communities,Microbial Community Compositions,Microbial Community Structures,Microbiomes,Microbiotas
D064806 Dysbiosis Changes in quantitative and qualitative composition of MICROBIOTA. The changes may lead to altered host microbial interaction or homeostatic imbalance that can contribute to a disease state often with inflammation. Disbacteriosis,Disbiosis,Dys-symbiosis,Dysbacteriosis,Disbacterioses,Disbioses,Dys symbiosis,Dys-symbioses,Dysbacterioses,Dysbioses

Related Publications

S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
October 2023, Protein & cell,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
January 2020, Experimental biology and medicine (Maywood, N.J.),
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
January 2021, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
January 2023, CNS & neurological disorders drug targets,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
January 2021, Frontiers in aging neuroscience,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
March 2021, Progress in neuro-psychopharmacology & biological psychiatry,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
October 2022, Sleep medicine reviews,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
September 2022, International journal of molecular sciences,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
October 2021, Pharmacological research,
S Hosie, and T Abo-Shaban, and C Y Q Lee, and S M Matta, and A Shindler, and R Gore, and S S Sharna, and M Herath, and P J Crack, and A E Franks, and E L Hill-Yardin
November 2023, Cell metabolism,
Copied contents to your clipboard!